BiomX Inc. (PHGE-UN)

USD 0.9

(-5.26%)

Eps Summary of BiomX Inc.

  • BiomX Inc.'s latest annual eps in 2023 was -5.10 USD , down -436.84% from previous year.
  • BiomX Inc.'s latest quarterly eps in 2024 Q2 was 0.64 USD , up 123.02% from previous quarter.
  • BiomX Inc. reported an annual eps of -9.49 USD in 2022, up 31.65% from previous year.
  • BiomX Inc. reported an annual eps of -13.93 USD in 2021, down -6.92% from previous year.
  • BiomX Inc. reported a quarterly eps of 0.64 USD for 2024 Q2, up 123.02% from previous quarter.
  • BiomX Inc. reported a quarterly eps of -0.12 USD for 2023 Q4, down -1804.76% from previous quarter.

Annual Eps Chart of BiomX Inc. (2023 - 2017)

Historical Annual Eps of BiomX Inc. (2023 - 2017)

Year Eps Eps Growth
2023 -5.10 USD -436.84%
2022 -9.49 USD 31.65%
2021 -13.93 USD -6.92%
2020 -12.97 USD 61.42%
2019 -8.36 USD 47.83%
2018 -6.46 USD -97.55%
2017 -3.27 USD 0.0%

Peer Eps Comparison of BiomX Inc.

Name Eps Eps Difference
AIM ImmunoTech Inc. -0.60 USD -750.0%
Ampio Pharmaceuticals, Inc. -10.67 USD 52.202%
Armata Pharmaceuticals, Inc. -1.91 USD -167.016%
Actinium Pharmaceuticals, Inc. -1.83 USD -178.689%
Azitra, Inc. -54.76 USD 90.687%
Can-Fite BioPharma Ltd. -1.79 USD -184.916%
Chromocell Therapeutics Corporation -1.28 USD -298.438%
Calidi Biotherapeutics, Inc. -1.73 USD -194.798%
CEL-SCI Corporation -0.73 USD -598.63%
iBio, Inc. -6.50 USD 21.538%
Lineage Cell Therapeutics, Inc. -0.12 USD -4150.0%
MAIA Biotechnology, Inc. -1.49 USD -242.282%
Matinas BioPharma Holdings, Inc. -5.28 USD 3.409%
Navidea Biopharmaceuticals, Inc. -0.59 USD -764.407%
NovaBay Pharmaceuticals, Inc. -138.65 USD 96.322%
NanoViricides, Inc. -0.70 USD -628.571%
Oragenics, Inc. -9.18 USD 44.444%
BiomX Inc. -5.10 USD -0.0%
Protalix BioTherapeutics, Inc. 0.12 USD 4350.0%
Palatin Technologies, Inc. -2.02 USD -152.475%
Scorpius Holdings, Inc. -347.20 USD 98.531%